AIDS Healthcare Foundation Urges African Nations to Ratify Treaty
The AHF is pushing for broader adoption of the African Medicines Agency Treaty to boost local pharmaceutical manufacturing capacity.
Updated on Oct. 29, 2026 in Healthcare
Live Poll
Should nations harmonize their regulatory standards to better ensure citizens have access to affordable medicines?
The AIDS Healthcare Foundation is calling on more African nations to ratify the African Medicines Agency Treaty to strengthen regional health systems. This push follows the inaugural week of the African Medicines Agency held in Kigali, Rwanda.
Why it matters
Fragmented regulatory systems currently hinder local pharmaceutical production, forcing the continent to rely on imported medicine for 70-95% of its supply. Harmonizing these standards could reduce trade deficits and improve medical access.
Eighty percent of local manufacturers identify unpredictable regulatory review timelines as a primary operational challenge. Additionally, 77% cite differing regulatory requirements as a major barrier to expansion.
The players
African Medicines Agency
This regulatory body aims to harmonize pharmaceutical standards and approval processes across the African continent.
AIDS Healthcare Foundation
This global non-profit organization provides medical services and advocacy to more than 3.3 million people across 50 countries.
The details
The African Medicines Agency seeks to facilitate shared assessments and collaborative inspections to address the inefficiencies reported by manufacturers. Currently, 54% of local producers struggle with the costs of duplicate submissions and assessments across different borders.
Timeline
The African Medicines Agency held its inaugural week in Kigali from October 25 to October 30, 2026.
By October 2026, 33 African Union Member States had ratified the treaty.
Africa recorded a pharmaceutical trade deficit of approximately US$12.5 billion in 2020.
Market Landscape
The push for the African Medicines Agency Treaty marks a strategic effort to consolidate fragmented regulatory frameworks into a unified continental system. This shift positions the region to reduce its reliance on external imports and scale internal production capacity.
Expanding local manufacturing could eventually lower costs and improve the availability of essential medicines for patients across the continent. Currently, the industry remains focused on regulatory changes that may impact long-term pricing and supply chain reliability.
The takeaway
Harmonizing regulations is a critical step for African nations to achieve greater independence in their pharmaceutical supply chains. Establishing a unified agency is expected to decrease the administrative burden that currently stifles local manufacturers.
Further reading
For more context on regional medical initiatives, visit the Healthcare section.
Source note: This article includes information reported by AFP.
Live Poll
Should nations harmonize their regulatory standards to better ensure citizens have access to affordable medicines?
